|
regulatory authority |
|
RA |
i~HD, UNICOM |
|
|
marketing authorisation |
medicinal product authorisation
|
MA |
OpenMedicine, concePTION, UNICOM, Gravitate-Health, i~HD |
|
|
medicinal product authorisation |
marketing authorisation
|
|
OpenMedicine, concePTION, UNICOM, Gravitate-Health, i~HD |
|
|
pharmaceutical product |
|
|
OpenMedicine, UNICOM, i~HD |
|
|
identifier |
|
ID |
i~HD, OpenMedicine, UNICOM |
|
|
international non-proprietary name |
|
INN |
OpenMedicine, concePTION, UNICOM, i~HD |
Regulatory |
|
medicinal product identifier |
|
MPID |
OpenMedicine, UNICOM, i~HD, Gravitate-Health |
|
|
marketing authorisation holder |
|
MAH |
OpenMedicine, concePTION, UNICOM, Gravitate-Health, i~HD |
|
|
packaged medicinal product |
|
|
OpenMedicine, UNICOM, i~HD |
|
|
eDispensing |
eDispensation
|
eD |
OpenMedicine, concePTION, UNICOM, Gravitate-Health, i~HD, XpanDH, xShare |
Information and communication technology |
|
ePrescription |
electronic prescription
|
eP |
OpenMedicine, UNICOM, concePTION, Gravitate-Health, i~HD, XpanDH, xShare |
Information and communication technology |
|
patient summary |
|
PS |
OpenMedicine, UNICOM, Gravitate-Health, i~HD, XpanDH |
|
|
controlled vocabulary |
|
CV |
OpenMedicine, UNICOM, i~HD |
|
|
dose form |
dosage form, pharmaceutical dose form
|
|
OpenMedicine, UNICOM, i~HD |
|
|
dosage form |
dose form, pharmaceutical dose form
|
|
OpenMedicine, UNICOM, i~HD |
|
|
pharmaceutical dose form |
dose form, dosage form
|
PDF |
OpenMedicine, UNICOM, i~HD |
|
|
global trade item number |
|
GTIN |
OpenMedicine, UNICOM, i~HD |
|
|
investigational medicinal product |
|
IMP |
OpenMedicine, concePTION, UNICOM, i~HD |
Clinical trials, Regulatory |
|
adverse drug reaction |
|
ADR |
OpenMedicine, UNICOM, Gravitate-Health, i~HD |
Healthcare, Pharmacovigilance |
|
healthcare professional |
health care professional
|
HCP |
OpenMedicine, UNICOM, i~HD, Gravitate-Health |
|
|
pharmaceutical product identifier |
|
PhPID |
OpenMedicine, UNICOM, i~HD, xShare, Gravitate-Health |
|
|
pharmacovigilance |
|
PhV |
OpenMedicine, concePTION, UNICOM, i~HD |
Pharmacokinetics, Pharmacovigilance |
|
unique device identifier |
|
UDI |
OpenMedicine, UNICOM, concePTION, i~HD |
Regulatory |
|
investigational medicinal product identifier |
|
IMPID |
OpenMedicine, UNICOM, i~HD |
|
|
summary of product characteristics |
|
SPC, SmPC |
OpenMedicine, concePTION, UNICOM, Gravitate-Health, i~HD |
Regulatory |
|
route of administration |
|
RoA |
OpenMedicine, UNICOM, i~HD |
|
|
medicines regulatory agency |
|
|
OpenMedicine, UNICOM, i~HD |
|
|
national contact point for eHealth |
|
NCPeH |
OpenMedicine, UNICOM, i~HD, XpanDH, xShare |
|
|
medicinal product dictionary system |
medicinal product dictionary
|
MPD |
OpenMedicine, UNICOM, i~HD |
|
|
molecular weight |
|
MW |
OpenMedicine, i~HD, UNICOM |
|
|
clinical decision support system |
clinical decision support
|
CDSS |
OpenMedicine, UNICOM, i~HD |
Healthcare, Information and communication technology |
|
electronic health record-system functional model |
|
EHR-S FM |
OpenMedicine, UNICOM, i~HD |
|
|
unified modeling language |
|
UML |
OpenMedicine, i~HD, UNICOM, Gravitate-Health |
|
|
uniform resource locator |
|
URL |
OpenMedicine, i~HD, UNICOM, Gravitate-Health |
|
|
object identifier |
|
OID |
OpenMedicine, UNICOM, i~HD |
|
|
unified code for units of measure |
|
UCUM |
OpenMedicine, UNICOM, i~HD |
|
|
British approved name |
|
BAN |
OpenMedicine, i~HD, UNICOM |
|
|
European pharmacopoeia |
|
EP |
OpenMedicine, i~HD, UNICOM |
|
|
Japanese accepted names |
|
JAN |
OpenMedicine, i~HD, UNICOM |
|
|
adverse event |
|
|
OpenMedicine, concePTION, i~HD, UNICOM |
Medicines |
|
active pharmaceutical ingredient |
active ingredient, active substance
|
API |
OpenMedicine, UNICOM, concePTION, i~HD |
Medicines |
|
manufacturer |
|
|
OpenMedicine, UNICOM, i~HD |
|
|
anatomical therapeutic chemical |
anatomical therapeutic chemical classification
|
ATC |
OpenMedicine, UNICOM, concePTION, i~HD |
Medicines |
|
electronic prescription |
ePrescription
|
EP |
OpenMedicine, UNICOM, concePTION, Gravitate-Health, i~HD, xShare |
|
|
anatomical therapeutic chemical classification |
anatomical therapeutic chemical
|
ATC |
UNICOM, OpenMedicine, concePTION, i~HD |
Medicines |
|
medicinal product batch identifier |
|
BAID |
UNICOM, OpenMedicine, i~HD |
|
|
biomedical research integrated domain group model |
|
BRIDG |
UNICOM, i~HD |
Clinical trials |
|
clinical document architecture |
|
CDA |
UNICOM, i~HD |
|
|
chemistry manufacturing and control |
|
CMC |
UNICOM, i~HD |
Medicines |
|
data carrier identifier |
|
DCID |
UNICOM, i~HD |
|
|
European Directorate for the Quality of Medicines & HealthCare |
|
EDQM |
UNICOM, OpenMedicine, Gravitate-Health, i~HD |
|
|
European economic area |
|
EEA |
UNICOM, i~HD |
|
|
European health data & evidence network |
|
EHDEN |
UNICOM, i~HD |
|
|
smart open services for European patients |
|
epSOS |
UNICOM, i~HD |
|
|
European surveillance of antibiotic consumption |
|
ESAC |
UNICOM, i~HD |
|
|
health care professional |
healthcare professional
|
HCP |
UNICOM, OpenMedicine, i~HD, Gravitate-Health |
|
|
investigational medicinal product batch identifier |
|
IBAID |
UNICOM, OpenMedicine, i~HD |
|
|
international council for harmonisation of technical requirements for pharmaceuticals for human use |
international conference on harmonisation, international council for harmonisation
|
ICH |
UNICOM, i~HD, xShare |
|
|
international consortium for health outcome measurement |
|
ICHOM |
UNICOM, i~HD, Gravitate-Health |
|
|
international classification of primary care |
|
ICPC |
UNICOM, i~HD |
|
|
individual case safety report |
|
ICSR |
UNICOM, OpenMedicine, Gravitate-Health, i~HD |
|
|
International Medical Devices Regulators Forum |
|
IMDRF |
UNICOM, OpenMedicine, i~HD |
|
|
investigational medicinal product package identifier |
|
IPCID |
UNICOM, OpenMedicine, i~HD |
|
|
international patient summary |
|
IPS |
UNICOM, Gravitate-Health, i~HD, xShare |
|
|
multi-market pack |
|
MMP |
UNICOM, i~HD |
|
|
national trade item number |
|
NTIN |
UNICOM, i~HD |
|
|
observational health data sciences and informatics |
|
OHDSI |
UNICOM, i~HD, xShare |
|
|
object management group |
|
OMG |
UNICOM, i~HD |
|
|
observational medical outcomes partnership |
|
OMOP |
UNICOM, i~HD, xShare |
|
|
medicinal product package identifier |
|
PCID |
UNICOM, OpenMedicine, i~HD |
|
|
national patient-centred clinical research network |
|
PCORnet |
UNICOM, i~HD |
|
|
stock keeping unit |
|
SKU |
UNICOM, i~HD |
|
|
single-market pack |
|
SMP |
UNICOM, i~HD |
|
|
SNOMED clinical terms |
|
SNOMED CT |
UNICOM, Gravitate-Health, i~HD, xShare |
|
|
World Health Organization |
|
WHO |
UNICOM, OpenMedicine, i~HD, xShare, Gravitate-Health |
|
|
WHO drug dictionary |
|
WHO-DD |
UNICOM, i~HD |
|
|
extended EudraVigilance medicinal product dictionary |
|
XEVMPD |
UNICOM, i~HD |
|
|
therapeutic moiety |
|
TM |
UNICOM, i~HD |
|
|
absorption |
|
|
concePTION, i~HD |
Biology |
|
access control |
|
|
concePTION, i~HD, AIDAVA |
Information governance |
|
accuracy |
|
|
concePTION, i~HD |
Statistics |
|
adaptive design |
|
|
concePTION, i~HD |
Clinical trials |
|
adjuvant |
|
|
concePTION, i~HD |
Medicines |
|
advanced therapy medicinal products |
|
ATMP |
concePTION, i~HD |
Medicines |
|
adverse drug event |
|
ADE |
concePTION, UNICOM, i~HD |
Pharmacokinetics, Pharmacovigilance |
|
adverse effect |
|
|
concePTION, i~HD |
Pharmacokinetics, Pharmacovigilance |
|
aetiology |
|
|
concePTION, i~HD |
Biology |
|
aggregated data |
|
|
concePTION, i~HD, AIDAVA |
Information governance |
|
allocation concealment |
|
|
concePTION, i~HD |
Clinical trials |
|
alternative hypothesis |
|
|
concePTION, i~HD |
Clinical trials |
|
anonymisation |
|
|
concePTION, i~HD, AIDAVA |
Information governance |
|
anonymised data |
|
|
concePTION, Gravitate-Health, i~HD, AIDAVA |
Information governance |
|
antenatal care |
|
|
concePTION, i~HD |
Maternity |
|
antibody |
|
AB |
concePTION, i~HD |
Biology |
|
antigen |
|
|
concePTION, i~HD |
Biology |
|
architecture |
|
|
concePTION, i~HD, AIDAVA |
Information and communication technology |
|
area under the curve |
|
AUC |
concePTION, i~HD |
Statistics |
|
arm |
|
|
concePTION, i~HD |
Clinical trials |
|
artificial intelligence |
|
AI |
concePTION, Gravitate-Health, i~HD, AIDAVA, xShare |
Information and communication technology |
|
attestation |
|
|
concePTION, i~HD, AIDAVA |
Information governance |
|
attrition |
|
|
concePTION, i~HD |
Clinical trials |
|
auditability |
|
|
concePTION, i~HD, AIDAVA |
Information governance |
|
autologous |
|
|
concePTION, i~HD |
Biology |
|
baseline assessments |
|
|
concePTION, i~HD |
Clinical trials |
|
baseline data |
|
|
concePTION, i~HD |
Clinical trials |
|
beneficence |
|
|
concePTION, i~HD |
Medicines |
|
benefit-risk assessment |
|
|
concePTION, i~HD |
Regulatory |
|
bias |
|
|
concePTION, i~HD |
Clinical trials |
|
big data |
|
|
concePTION, i~HD, AIDAVA |
Information and communication technology |
|
binary endpoint |
|
|
concePTION, i~HD |
Clinical trials |
|
bioassay |
|
|
concePTION, i~HD |
Biology |
|
biobank |
|
|
concePTION, i~HD |
Clinical trials |
|
bioequivalence |
|
|
concePTION, i~HD |
Clinical trials |
|
bioequivalence study |
|
|
concePTION, i~HD |
Clinical trials |
|
biologic medicine |
biopharmaceutical
|
|
concePTION, i~HD |
Medicines |
|
biopharmaceutical |
biologic medicine
|
|
concePTION, i~HD |
Medicines |
|
biomarker |
|
|
concePTION, i~HD |
Biology |
|
biometric data |
|
|
concePTION, i~HD, AIDAVA |
Information governance |
|
biosimilar medicine |
|
|
concePTION, i~HD |
Medicines |
|
biotechnology |
|
|
concePTION, i~HD |
Medicines |
|
biotransformation |
|
|
concePTION, i~HD |
Medicines |
|
birth weight |
|
|
concePTION, i~HD |
Maternity |
|
blinding |
|
|
concePTION, i~HD |
Clinical trials |
|
branded medicines |
|
|
concePTION, i~HD |
Medicines |
|
breast milk exposure |
|
|
concePTION, i~HD |
Pharmacokinetics, Pharmacovigilance |
|
breastfeeding |
|
|
concePTION, i~HD |
Maternity |
|
budget impact |
|
|
concePTION, i~HD |
Regulatory |
|
carcinogenicity studies |
|
|
concePTION, i~HD |
Clinical trials |
|
care plan |
|
|
concePTION, i~HD |
Healthcare |
|
case control studies |
|
|
concePTION, i~HD |
Clinical trials |
|
case report form |
|
|
concePTION, i~HD |
Clinical trials |
|
centralised procedure |
|
CP |
concePTION, i~HD |
Regulatory |
|
childbearing age |
|
|
concePTION, i~HD |
Maternity |
|
chronic condition |
|
|
concePTION, i~HD |
Medicines |
|
class effect |
|
|
concePTION, i~HD |
Pharmacokinetics, Pharmacovigilance |
|
clearance |
|
|
concePTION, i~HD |
Medicines |
|
clinical effectiveness |
|
|
concePTION, i~HD |
Regulatory |
|
clinical efficacy |
|
|
concePTION, i~HD |
Regulatory |
|
clinical information |
|
|
concePTION, i~HD, AIDAVA |
Healthcare |
|
clinical phase |
|
|
concePTION, i~HD |
Clinical trials |
|
clinical process |
|
|
concePTION, i~HD |
Healthcare |
|
clinical study report |
|
CSR |
concePTION, i~HD |
Clinical trials |
|
clinicaltrials.gov |
|
|
concePTION, i~HD |
Clinical trials |
|
cloud computing |
|
|
concePTION, i~HD, AIDAVA |
Information and communication technology |
|
coefficient of variation |
|
CV |
concePTION, i~HD |
Statistics |
|
cohort studies |
|
|
concePTION, i~HD |
Clinical trials |
|
combined advanced-therapy medicines |
|
|
concePTION, i~HD |
Medicines |
|
Committee for Medicinal Products for Human Use |
|
CHMP |
concePTION, i~HD |
Medicines |
|
common technical document |
|
CTD |
concePTION, i~HD |
Regulatory |
|
compassionate use |
|
|
concePTION, i~HD |
Regulatory |
|
computational model |
|
|
concePTION, i~HD |
Statistics |
|
concomitant |
|
|
concePTION, i~HD |
Medicines |
|
confidence interval |
|
|
concePTION, i~HD |
Statistics |
|
confidentiality |
|
|
concePTION, i~HD, AIDAVA |
Information governance |
|
confirmatory studies |
|
|
concePTION, i~HD |
Clinical trials |
|
confounder |
|
|
concePTION, i~HD |
Clinical trials |
|
confounding variable |
|
|
concePTION, i~HD |
Statistics |
|
congenital abnormality |
congenital malformation
|
|
concePTION, i~HD |
Pharmacokinetics, Pharmacovigilance |
|
congenital malformation |
congenital abnormality
|
|
concePTION, i~HD |
Pharmacokinetics, Pharmacovigilance |
|
congenital anomaly |
|
|
concePTION, i~HD |
Pharmacokinetics, Pharmacovigilance |
|
consent |
|
|
concePTION, i~HD, AIDAVA |
Information governance |
|
consent (assumed) |
assumed consent
|
|
concePTION, i~HD, AIDAVA |
Information governance |
|
assumed consent |
consent (assumed)
|
|
concePTION, i~HD, AIDAVA |
Information governance |
|
consent (explicit) |
explicit consent
|
|
concePTION, i~HD, AIDAVA |
Information governance |
|
explicit consent |
consent (explicit)
|
|
concePTION, i~HD, AIDAVA |
Information governance |
|
consent (implied) |
implied consent
|
|
concePTION, i~HD, AIDAVA |
Information governance |
|
implied consent |
consent (implied)
|
|
concePTION, i~HD, AIDAVA |
Information governance |
|
continuity of care |
|
|
concePTION, i~HD |
Healthcare |
|
continuous endpoint |
|
|
concePTION, i~HD |
Clinical trials |
|
contract research organisation |
|
CRO |
concePTION, i~HD |
Clinical trials |
|
cost effectiveness |
|
|
concePTION, i~HD |
Regulatory |
|
covariance |
|
|
concePTION, i~HD |
Statistics |
|
covariate |
|
|
concePTION, i~HD |
Statistics |
|
cross-sectional study |
|
|
concePTION, i~HD |
Clinical trials |
|
cybersecurity |
|
|
concePTION, Gravitate-Health, i~HD, AIDAVA |
Information and communication technology |
|
cytotoxicity |
|
|
concePTION, i~HD |
Pharmacokinetics, Pharmacovigilance |
|
Data and Safety Monitoring Board |
|
DSMB |
concePTION, i~HD |
Clinical trials |
|
data controller |
controller
|
|
concePTION, Gravitate-Health, i~HD, AIDAVA |
Information governance |
|
controller |
data controller
|
|
concePTION, Gravitate-Health, i~HD, AIDAVA |
Information governance |
|
data destruction |
|
|
concePTION, i~HD, AIDAVA |
Information governance |
|
data dictionary |
|
|
concePTION, i~HD, AIDAVA |
Information and communication technology |
|
data element |
|
|
concePTION, i~HD, AIDAVA |
Information governance |
|
data exclusivity |
|
|
concePTION, i~HD |
Regulatory |
|
data linkage |
|
|
concePTION, i~HD, AIDAVA |
Information governance |
|
data model |
|
|
concePTION, i~HD, AIDAVA |
Information governance |
|
data processor |
|
|
concePTION, Gravitate-Health, i~HD, AIDAVA |
Information governance |
|
data sharing |
|
|
concePTION, i~HD, AIDAVA |
Information governance |
|
data sharing agreement |
|
|
concePTION, i~HD, AIDAVA |
Information governance |
|
data subject |
|
|
concePTION, i~HD, AIDAVA |
Information governance |
|
database |
|
|
concePTION, i~HD, AIDAVA, Gravitate-Health |
Information and communication technology |
|
deep learning |
|
DL |
concePTION, i~HD, AIDAVA |
Information and communication technology |
|
degradants |
|
|
concePTION, i~HD |
Medicines |
|
determinant |
|
|
concePTION, i~HD |
Statistics |
|
development safety update report |
|
DSUR |
concePTION, i~HD |
Regulatory |
|
developmental and reproductive toxicity |
|
DART |
concePTION, i~HD |
Pharmacokinetics, Pharmacovigilance |
|
digital health literacy |
|
|
concePTION, i~HD, AIDAVA |
Information and communication technology |
|
directive |
|
|
concePTION, i~HD |
Regulatory |
|
disability-adjusted life year |
|
DALY |
concePTION, i~HD |
Regulatory |
|
disclose |
|
|
concePTION, i~HD, AIDAVA |
Information governance |
|
disclosure control |
|
|
concePTION, i~HD, AIDAVA |
Information governance |
|
disease burden |
|
|
concePTION, i~HD |
Regulatory |
|
dosage |
|
|
concePTION, i~HD |
Medicines |
|
dosage forms |
|
|
concePTION, i~HD |
Medicines |
|
dosage regimen |
|
|
concePTION, i~HD |
Medicines |
|
double blind |
|
|
concePTION, i~HD |
Statistics |
|
drug |
|
|
concePTION, UNICOM, i~HD |
Medicines |
|
drug candidate |
|
|
concePTION, i~HD |
Medicines |
|
Drug Information Association |
|
DIA |
concePTION, i~HD |
Medicines |
|
drug tolerance |
|
|
concePTION, i~HD |
Medicines |
|
ectopic pregnancy |
|
|
concePTION, i~HD |
Maternity |
|
Effective Concentration 50 (EC50) and Inhibition Concentration 50 (IC50) |
|
EC50 & IC50 |
concePTION, i~HD |
Pharmacokinetics, Pharmacovigilance |
|
effectiveness |
|
|
concePTION, i~HD |
Regulatory |
|
efficacy |
|
|
concePTION, i~HD |
Regulatory |
|
efficiency |
|
|
concePTION, i~HD |
Regulatory |
|
elective abortion |
|
|
concePTION, i~HD |
Maternity |
|
electronic health record architecture |
|
|
concePTION, i~HD, AIDAVA |
Information and communication technology |
|
electronic health record system |
|
|
concePTION, UNICOM, i~HD, AIDAVA |
Information and communication technology |
|
electronic product information |
|
ePI |
concePTION, i~HD |
Regulatory |
|
eligibility |
|
|
concePTION, i~HD |
Clinical trials |
|
embryo |
|
|
concePTION, i~HD |
Maternity |
|
embryogenesis |
|
|
concePTION, i~HD |
Biology |
|
encryption |
|
|
concePTION, i~HD, AIDAVA |
Information and communication technology |
|
endpoint |
|
|
concePTION, i~HD |
Clinical trials |
|
engagement |
|
|
concePTION, i~HD |
Healthcare |
|
epigenetics |
|
|
concePTION, i~HD |
Biology |
|
epigenomics |
|
|
concePTION, i~HD |
Biology |
|
EUnetHTA |
|
|
concePTION, i~HD |
Regulatory |
|
EuroBioBank |
|
|
concePTION, i~HD |
Clinical trials |
|
European public assessment report |
|
EPAR |
concePTION, i~HD |
Regulatory |
|
evidence-based medicine |
|
EBM |
concePTION, i~HD |
Medicines |
|
exclusion criteria |
|
|
concePTION, i~HD |
Clinical trials |
|
exploratory trials |
|
|
concePTION, i~HD |
Clinical trials |
|
extractables |
|
|
concePTION, i~HD |
Medicines |
|
foetal death |
intrauterine death
|
|
concePTION, i~HD |
Maternity |
|
intrauterine death |
foetal death
|
|
concePTION, i~HD |
Maternity |
|
foetotoxic effect |
|
|
concePTION, i~HD |
Pharmacokinetics, Pharmacovigilance |
|
foetus |
fetus
|
|
concePTION, i~HD |
Maternity |
|
fetus |
foetus
|
|
concePTION, i~HD |
Maternity |
|
food and drug administration |
|
|
concePTION, i~HD |
Medicines |
|
formulation |
|
|
concePTION, i~HD |
Medicines |
|
gene mutation |
|
|
concePTION, i~HD |
Biology |
|
gene therapy |
|
|
concePTION, i~HD |
Biology |
|
general data protection regulation |
|
GDPR |
concePTION, UNICOM, Gravitate-Health, i~HD, AIDAVA, XpanDH, xShare |
Information governance |
|
general practitioner |
|
GP |
concePTION, UNICOM, i~HD, XpanDH, xShare, Gravitate-Health |
Healthcare |
|
genetic data |
|
|
concePTION, i~HD, AIDAVA |
Information governance |
|
genetic data |
|
|
concePTION, i~HD |
Information governance |
|
genetically modified organism |
|
GMO |
concePTION, i~HD |
Biology |
|
genome |
|
|
concePTION, i~HD |
Biology |
|
genome-wide association study |
|
GWAS |
concePTION, i~HD |
Clinical trials |
|
genome-wide inferred study |
|
GWIS |
concePTION, i~HD |
Clinical trials |
|
genomic marker |
|
|
concePTION, i~HD |
Biology |
|
genotoxicity study |
|
|
concePTION, i~HD |
Pharmacokinetics, Pharmacovigilance |
|
genotoxin |
|
|
concePTION, i~HD |
Biology |
|
genotype |
|
|
concePTION, i~HD |
Biology |
|
genotyping |
|
|
concePTION, i~HD |
Biology |
|
gestational age |
|
Trimester |
concePTION, i~HD |
Maternity |
|
gold standard |
|
|
concePTION, i~HD |
Biology |
|
Good Clinical Practice |
|
GCP |
concePTION, i~HD |
Clinical trials |
|
Good Distribution Practice |
|
GDP |
concePTION, i~HD |
Regulatory |
|
Good Laboratory Practice |
|
GLP |
concePTION, i~HD |
Clinical trials |
|
Good Manufacturing Practice |
|
GMP |
concePTION, i~HD |
Regulatory |
|
Good Pharmacovigilance Practices |
|
GVP |
concePTION, UNICOM, i~HD, Gravitate-Health |
Pharmacokinetics, Pharmacovigilance |
|
group sequential design |
|
|
concePTION, i~HD |
Clinical trials |
|
guarantee-time bias |
|
|
concePTION, i~HD |
Clinical trials |
|
half life |
|
|
concePTION, i~HD |
Medicines |
|
hard endpoint |
|
|
concePTION, i~HD |
Medicines |
|
hazard ratio |
|
|
concePTION, i~HD |
Statistics |
|
Heads of Medicines Agencies |
|
HMA |
concePTION, UNICOM, i~HD |
Medicines |
|
health information |
|
|
concePTION, i~HD, AIDAVA |
Information and communication technology |
|
health technology assessment |
|
HTA |
concePTION, i~HD |
Regulatory |
|
health-related quality of life |
|
HRQoL |
concePTION, i~HD |
Regulatory |
|
healthcare |
|
|
concePTION, i~HD |
Healthcare |
|
healthcare activity |
|
|
concePTION, i~HD |
Healthcare |
|
healthcare provider organisation |
healthcare provider
|
|
concePTION, UNICOM, i~HD |
Healthcare |
|
healthcare provider |
healthcare provider organisation
|
|
concePTION, UNICOM, i~HD |
Healthcare |
|
herd immunity |
|
|
concePTION, i~HD |
Medicines |
|
high performance liquid chromatography |
|
HPLC |
concePTION, i~HD |
Pharmacokinetics, Pharmacovigilance |
|
human biological sample |
|
|
concePTION, i~HD, AIDAVA |
Information governance |
|
human mammary epithelial cells |
|
HMECs |
concePTION, i~HD |
Biology |
|
idiosyncratic drug reaction |
|
|
concePTION, i~HD |
Medicines |
|
immunogenic |
|
|
concePTION, i~HD |
Medicines |
|
immunotoxicity |
|
|
concePTION, i~HD |
Pharmacokinetics, Pharmacovigilance |
|
in silico |
|
|
concePTION, i~HD |
Pharmacokinetics, Pharmacovigilance |
|
in utero |
|
|
concePTION, i~HD |
Maternity |
|
in vitro |
|
|
concePTION, i~HD |
Pharmacokinetics, Pharmacovigilance |
|
in vitro to in vivo extrapolation |
|
IVIVE |
concePTION, i~HD |
Pharmacokinetics, Pharmacovigilance |
|
in vivo |
|
|
concePTION, i~HD |
Pharmacokinetics, Pharmacovigilance |
|
incidental finding |
|
|
concePTION, i~HD, AIDAVA |
Information governance |
|
indication |
|
|
concePTION, i~HD |
Medicines |
|
induced abortion |
|
|
concePTION, i~HD |
Maternity |
|
information governance |
|
|
concePTION, i~HD |
Information governance |
|
information governance |
|
IG |
concePTION, i~HD, AIDAVA |
Information governance |
|
information model |
|
|
concePTION, i~HD, AIDAVA |
Information and communication technology |
|
integrated care |
|
|
concePTION, i~HD |
Healthcare |
|
integrity |
|
|
concePTION, i~HD, AIDAVA |
Information governance |
|
intention-to-treat |
|
ITT |
concePTION, i~HD |
Clinical trials |
|
interim analysis |
|
|
concePTION, i~HD |
Clinical trials |
|
intermediate endpoint |
|
|
concePTION, i~HD |
Clinical trials |
|
internal validity |
|
|
concePTION, i~HD |
Clinical trials |
|
international conference on harmonisation |
international council for harmonisation of technical requirements for pharmaceuticals for human use, international council for harmonisation
|
ICH |
concePTION, UNICOM, i~HD, xShare |
Medicines |
|
international council for harmonisation |
international council for harmonisation of technical requirements for pharmaceuticals for human use, international conference on harmonisation
|
ICH |
concePTION, UNICOM, i~HD, xShare |
Regulatory |
|
International Organisation for Standardization |
|
ISO |
concePTION, OpenMedicine, UNICOM, i~HD, XpanDH, xShare, Gravitate-Health |
|
|
Internet of Things |
|
IoT |
concePTION, i~HD, AIDAVA |
Information and communication technology |
|
interventional study |
|
|
concePTION, i~HD |
Clinical trials |
|
intrauterine growth retardation |
small for gestational age
|
IUGR, SGA |
concePTION, i~HD |
Maternity |
|
small for gestational age |
intrauterine growth retardation
|
|
concePTION, i~HD |
Maternity |
|
intravenous |
|
|
concePTION, i~HD |
Medicines |
|
Investigational Medicinal Product Dossier |
|
IMPD |
concePTION, i~HD |
Clinical trials |
|
knowledge model |
|
|
concePTION, i~HD, AIDAVA |
Information and communication technology |
|
lactation |
|
|
concePTION, i~HD |
Maternity |
|
lead-time bias |
|
|
concePTION, i~HD |
Clinical trials |
|
Learning Health System |
|
|
concePTION, i~HD |
Healthcare |
|
legally authorised representative |
|
LAR |
concePTION, i~HD |
Regulatory |
|
life years |
|
LY |
concePTION, i~HD |
Clinical trials |
|
lifetime prevalence |
|
LTP |
concePTION, i~HD |
Clinical trials |
|
limit of detection |
|
LOD |
concePTION, i~HD |
Pharmacokinetics, Pharmacovigilance |
|
limits of quantification |
|
LOQ |
concePTION, i~HD |
Pharmacokinetics, Pharmacovigilance |
|
lipophilicity |
|
|
concePTION, i~HD |
Pharmacokinetics, Pharmacovigilance |
|
live birth |
|
|
concePTION, i~HD |
Maternity |
|
log-rank test |
|
|
concePTION, i~HD |
Statistics |
|
low birth weight baby |
|
|
concePTION, i~HD |
Maternity |
|
low-intervention clinical trial |
|
|
concePTION, i~HD |
Clinical trials |
|
market exclusivity |
|
|
concePTION, i~HD |
Regulatory |
|
marketing authorisation application |
|
MAA |
concePTION, UNICOM, i~HD |
Medicines |
|
mass spectrometry |
|
MS |
concePTION, i~HD |
Pharmacokinetics, Pharmacovigilance |
|
mathematical model |
|
|
concePTION, i~HD |
Pharmacokinetics, Pharmacovigilance |
|
maximum tolerated dose |
|
MTD |
concePTION, i~HD |
Medicines |
|
mediator variable |
|
|
concePTION, i~HD |
Statistics |
|
medical data |
|
|
concePTION, i~HD, AIDAVA |
Information governance |
|
medical technology assessment |
|
MTA |
concePTION, i~HD |
Clinical trials |
|
medication error |
|
|
concePTION, i~HD |
Medicines |
|
medication list |
|
|
concePTION, i~HD |
Medicines |
|
medicine |
|
|
concePTION, i~HD |
Medicines |
|
medicine distribution |
drug distribution
|
|
concePTION, i~HD |
Pharmacokinetics, Pharmacovigilance |
|
drug distribution |
medicine distribution
|
|
concePTION, i~HD |
Pharmacokinetics, Pharmacovigilance |
|
medicine model structure |
drug model structure
|
|
concePTION, i~HD |
Pharmacokinetics, Pharmacovigilance |
|
drug model structure |
medicine model structure
|
|
concePTION, i~HD |
Pharmacokinetics, Pharmacovigilance |
|
medicine specific parameters |
drug specific parameters
|
|
concePTION, i~HD |
Pharmacokinetics, Pharmacovigilance |
|
drug specific parameters |
medicine specific parameters
|
|
concePTION, i~HD |
Pharmacokinetics, Pharmacovigilance |
|
medicine transfer |
drug transfer
|
|
concePTION, i~HD |
Pharmacokinetics, Pharmacovigilance |
|
drug transfer |
medicine transfer
|
|
concePTION, i~HD |
Pharmacokinetics, Pharmacovigilance |
|
medicines list |
medicines formulary
|
|
concePTION, i~HD |
Medicines |
|
medicines formulary |
medicines list
|
|
concePTION, i~HD |
Medicines |
|
medicines management |
|
|
concePTION, i~HD |
Medicines |
|
medicines monitoring |
drug monitoring
|
|
concePTION, i~HD |
Medicines |
|
drug monitoring |
medicines monitoring
|
|
concePTION, i~HD |
Medicines |
|
medicines optimisation |
|
|
concePTION, i~HD |
Medicines |
|
meta-analysis |
|
|
concePTION, i~HD |
Statistics |
|
metabolome |
|
|
concePTION, i~HD |
Biology |
|
microarray |
|
|
concePTION, i~HD |
Biology |
|
milk-to-plasma ratio |
|
M/P ratio |
concePTION, i~HD |
Pharmacokinetics, Pharmacovigilance |
|
minimal anticipated biological effect level |
|
MABEL |
concePTION, i~HD |
Medicines |
|
miscarriage |
spontaneous abortion
|
|
concePTION, i~HD |
Maternity |
|
spontaneous abortion |
miscarriage
|
|
concePTION, i~HD |
Maternity |
|
mobile health |
mHealth
|
|
concePTION, i~HD, AIDAVA |
Information and communication technology |
|
mHealth |
mobile health
|
|
concePTION, i~HD, AIDAVA |
Information and communication technology |
|
moderator variable |
|
|
concePTION, i~HD |
Statistics |
|
molecular biomarker |
|
|
concePTION, i~HD |
Biology |
|
multi-arm multi-stage |
|
MAMS |
concePTION, i~HD |
Clinical trials |
|
multiplicity |
|
|
concePTION, i~HD |
Clinical trials |
|
mutual recognition procedure |
|
MRP |
concePTION, UNICOM, i~HD |
Regulatory |
|
neonatal physiological factors |
|
|
concePTION, i~HD |
Pharmacokinetics, Pharmacovigilance |
|
new drug application |
|
NDA |
concePTION, UNICOM, i~HD |
Regulatory |
|
new molecular entity |
|
NME |
concePTION, i~HD |
Medicines |
|
no observed adverse effect level |
|
NOAEL |
concePTION, i~HD |
Clinical trials |
|
non-clinical testing |
|
|
concePTION, i~HD |
Clinical trials |
|
non-interventional observational study |
|
|
concePTION, i~HD |
Clinical trials |
|
non-maleficence |
|
|
concePTION, i~HD |
Medicines |
|
non-randomised trial |
|
|
concePTION, i~HD |
Clinical trials |
|
null hypothesis |
|
|
concePTION, i~HD |
Statistics |
|
number-needed-to-treat |
|
NNT |
concePTION, i~HD |
Clinical trials |
|
observational study |
|
|
concePTION, i~HD |
Clinical trials |
|
observer bias |
|
|
concePTION, i~HD |
Clinical trials |
|
observer-reported outcome |
|
ObsRO |
concePTION, i~HD |
Clinical trials |
|
off label use |
|
|
concePTION, i~HD |
Medicines |
|
off-label use |
|
|
concePTION, i~HD |
Regulatory |
|
Official Medicines Control Laboratory |
|
OMCL |
concePTION, i~HD |
Regulatory |
|
organisation |
|
|
concePTION, i~HD, AIDAVA |
Information and communication technology |
|
orphan designation |
|
|
concePTION, i~HD |
Regulatory |
|
overdose |
|
|
concePTION, i~HD |
Medicines |
|
p-value |
|
|
concePTION, i~HD |
Regulatory |
|
package insert |
|
|
concePTION, i~HD |
Medicines |
|
parameter |
|
|
concePTION, i~HD |
Statistics |
|
parenteral |
|
|
concePTION, i~HD |
Medicines |
|
passive surveillance |
|
|
concePTION, i~HD |
Clinical trials |
|
pathogen |
|
|
concePTION, i~HD |
Biology |
|
patient |
|
|
concePTION, UNICOM, i~HD |
Healthcare |
|
patient harm |
|
|
concePTION, i~HD |
Healthcare |
|
patient registry |
|
|
concePTION, i~HD |
Clinical trials |
|
patient years |
|
|
concePTION, i~HD |
Statistics |
|
patient-reported outcome |
|
PRO |
concePTION, i~HD |
Clinical trials |
|
patient reported outcome measures |
|
PROMs |
concePTION, UNICOM, i~HD |
Clinical trials |
|
pbpk platform |
|
|
concePTION, i~HD |
Pharmacokinetics, Pharmacovigilance |
|
per protocol analysis |
|
|
concePTION, i~HD |
Regulatory |
|
performance-linked access system |
|
|
concePTION, i~HD |
Pharmacokinetics, Pharmacovigilance |
|
period of exclusivity |
|
|
concePTION, i~HD |
Regulatory |
|
periodic benefit risk evaluation report |
|
PBRER |
concePTION, i~HD |
Regulatory |
|
periodic safety update report |
|
PSUR |
concePTION, i~HD |
Regulatory |
|
persisted |
|
|
concePTION, i~HD, AIDAVA |
Information and communication technology |
|
person identification |
|
|
concePTION, i~HD, AIDAVA |
Information governance |
|
personal data |
|
|
concePTION, Gravitate-Health, i~HD, AIDAVA |
Information governance |
|
personal health record |
|
|
concePTION, i~HD, AIDAVA |
Information and communication technology |
|
personalised medicine |
|
PM |
concePTION, i~HD |
Biology |
|
perturbation |
|
|
concePTION, i~HD, AIDAVA |
Information governance |
|
pharmacodynamics |
|
PD |
concePTION, i~HD |
Pharmacokinetics, Pharmacovigilance |
|
pharmacoepidemiology |
|
|
concePTION, i~HD |
Biology |
|
pharmacogenetics |
|
|
concePTION, i~HD |
Biology |
|
pharmacogenomics |
|
PG |
concePTION, i~HD |
Biology |
|
pharmacokinetic study |
|
|
concePTION, i~HD |
Clinical trials |
|
pharmacokinetics |
|
PK |
concePTION, i~HD |
Pharmacokinetics, Pharmacovigilance |
|
pharmacology |
|
|
concePTION, i~HD |
Biology |
|
pharmacopoeia |
|
|
concePTION, i~HD |
Medicines |
|
Phase 0 Trials |
|
|
concePTION, i~HD |
Clinical trials |
|
Phase I Trials |
|
|
concePTION, i~HD |
Clinical trials |
|
Phase II Trials |
|
|
concePTION, i~HD |
Clinical trials |
|
Phase III Trials |
|
|
concePTION, i~HD |
Clinical trials |
|
Phase IV Trials |
|
|
concePTION, i~HD |
Clinical trials |
|
physiology-based pharmacokinetic models |
physiologically-based toxicokinetic models
|
PBPK, PBTK |
concePTION, i~HD |
Pharmacokinetics, Pharmacovigilance |
|
physiologically-based toxicokinetic models |
physiology-based pharmacokinetic models
|
|
concePTION, i~HD |
Pharmacokinetics, Pharmacovigilance |
|
pivotal study |
|
|
concePTION, i~HD |
Clinical trials |
|
PK-Sim® |
|
|
concePTION, i~HD |
Pharmacokinetics, Pharmacovigilance |
|
placebo |
|
|
concePTION, i~HD |
Clinical trials |
|
placebo-controlled |
|
|
concePTION, i~HD |
Clinical trials |
|
plasma |
|
|
concePTION, i~HD |
Biology |
|
policy |
|
|
concePTION, i~HD, AIDAVA |
Information governance |
|
polymerase chain reaction |
|
PCR |
concePTION, i~HD |
Biology |
|
population |
|
|
concePTION, i~HD |
Clinical trials |
|
population pharmacokinetics |
|
|
concePTION, i~HD |
Pharmacokinetics, Pharmacovigilance |
|
post authorisation safety study |
|
PASS |
concePTION, i~HD |
Clinical trials |
|
post marketing |
|
|
concePTION, i~HD |
Regulatory |
|
post-authorisation efficacy study |
|
PAES |
concePTION, i~HD |
Regulatory |
|
post-marketing surveillance study |
|
PMS |
concePTION, i~HD |
Regulatory |
|
power |
|
|
concePTION, i~HD |
Statistics |
|
pre-embryo |
|
|
concePTION, i~HD |
Maternity |
|
predictive genetic test |
|
|
concePTION, i~HD |
Regulatory |
|
predictive medicine |
|
|
concePTION, i~HD |
Medicines |
|
predictive performance of medicine model |
predictive performance of drug model
|
|
concePTION, i~HD |
Pharmacokinetics, Pharmacovigilance |
|
predictive performance of drug model |
predictive performance of medicine model
|
|
concePTION, i~HD |
Pharmacokinetics, Pharmacovigilance |
|
pregnancy outcome |
|
|
concePTION, i~HD |
Maternity |
|
premature (baby) |
preterm baby
|
|
concePTION, i~HD |
Maternity |
|
preterm baby |
premature (baby)
|
|
concePTION, i~HD |
Maternity |
|
prescribe |
|
|
concePTION, i~HD |
Medicines |
|
prevalence |
|
|
concePTION, i~HD |
Statistics |
|
preventable |
|
|
concePTION, i~HD |
Pharmacokinetics, Pharmacovigilance |
|
preventable patient harm |
|
|
concePTION, i~HD |
Pharmacokinetics, Pharmacovigilance |
|
privacy |
|
|
concePTION, i~HD, AIDAVA |
Information governance |
|
prn |
|
PRN |
concePTION, i~HD |
Medicines |
|
process |
|
|
concePTION, i~HD, AIDAVA |
Information and communication technology |
|
proof of concept |
|
POC |
concePTION, i~HD |
Clinical trials |
|
proof of mechanism |
|
POM |
concePTION, i~HD |
Clinical trials |
|
prophylactic vaccine |
|
|
concePTION, i~HD |
Medicines |
|
prospective cohort study |
|
|
concePTION, i~HD |
Clinical trials |
|
prospective data collection |
|
|
concePTION, i~HD, AIDAVA |
Information governance |
|
prospective meta-analysis |
|
|
concePTION, i~HD |
Clinical trials |
|
proteome |
|
|
concePTION, i~HD |
Biology |
|
proteomic marker |
|
|
concePTION, i~HD |
Biology |
|
proteomics |
|
|
concePTION, i~HD |
Biology |
|
pseudonym |
|
|
concePTION, i~HD, AIDAVA |
Information governance |
|
pseudonymisation |
|
|
concePTION, i~HD, AIDAVA |
Information governance |
|
pseudonymised data |
|
|
concePTION, i~HD, AIDAVA |
Information governance |
|
public health |
|
|
concePTION, UNICOM, i~HD |
Healthcare |
|
public interest |
|
|
concePTION, i~HD |
Healthcare |
|
qualitative study |
|
|
concePTION, i~HD |
Clinical trials |
|
quality control |
|
QC |
concePTION, i~HD |
Clinical trials |
|
quality of life |
|
QoL |
concePTION, i~HD |
Regulatory |
|
quality-adjusted life year |
|
QALY |
concePTION, i~HD |
Regulatory |
|
quantitative study |
|
|
concePTION, i~HD |
Clinical trials |
|
quasi-randomised trial |
|
|
concePTION, i~HD |
Clinical trials |
|
randomisation |
|
|
concePTION, i~HD |
Clinical trials |
|
randomised clinical trial |
|
|
concePTION, i~HD |
Clinical trials |
|
randomised controlled trial |
|
RCT |
concePTION, i~HD |
Clinical trials |
|
randomised participants |
|
|
concePTION, i~HD |
Clinical trials |
|
rare disease |
|
|
concePTION, i~HD |
Biology |
|
re-identification |
|
|
concePTION, i~HD, AIDAVA |
Information governance |
|
real word evidence |
|
RWE |
concePTION, Gravitate-Health, i~HD, AIDAVA |
Information and communication technology |
|
real world data |
|
RWD |
concePTION, Gravitate-Health, i~HD, AIDAVA, xShare |
Information and communication technology |
|
reassortant vaccine |
|
|
concePTION, i~HD |
Medicines |
|
recombinant DNA |
|
rDNA |
concePTION, i~HD |
Biology |
|
recombinant gene |
|
|
concePTION, i~HD |
Biology |
|
recruitment |
|
|
concePTION, i~HD |
Clinical trials |
|
relative clinical effectiveness |
|
|
concePTION, i~HD |
Regulatory |
|
relative efficacy |
|
|
concePTION, i~HD |
Regulatory |
|
relevance |
|
|
concePTION, i~HD |
Statistics |
|
reliability |
|
|
concePTION, i~HD |
Statistics |
|
remission |
|
|
concePTION, i~HD |
Biology |
|
replacement feeding |
|
|
concePTION, i~HD |
Maternity |
|
replacement, reduction and refinement |
|
|
concePTION, i~HD |
Pharmacokinetics, Pharmacovigilance |
|
reproductive toxicology |
|
|
concePTION, i~HD |
Pharmacokinetics, Pharmacovigilance |
|
repurposing |
|
|
concePTION, i~HD |
Regulatory |
|
research |
|
|
concePTION, i~HD, AIDAVA |
Information governance |
|
response variable |
|
|
concePTION, i~HD |
Clinical trials |
|
retrospective case control study |
|
|
concePTION, i~HD |
Clinical trials |
|
risk |
|
|
concePTION, i~HD |
Regulatory |
|
risk assessment |
|
|
concePTION, i~HD |
Regulatory |
|
risk evaluation and mitigation strategy |
|
REMS |
concePTION, i~HD |
Regulatory |
|
risk factor |
|
|
concePTION, i~HD |
Regulatory |
|
risk management |
|
|
concePTION, i~HD |
Regulatory |
|
risk management plan |
|
RMP |
concePTION, i~HD, Gravitate-Health |
Regulatory |
|
risk minimisation measures |
|
|
concePTION, i~HD, Gravitate-Health |
Regulatory |
|
robustness |
|
|
concePTION, i~HD |
Pharmacokinetics, Pharmacovigilance |
|
safety signal |
|
|
concePTION, i~HD |
Pharmacokinetics, Pharmacovigilance |
|
safety specification |
|
|
concePTION, i~HD |
Pharmacokinetics, Pharmacovigilance |
|
sample size |
|
|
concePTION, i~HD |
Clinical trials |
|
Scientific Advice Working Party |
|
SAWP |
concePTION, i~HD |
Regulatory |
|
Scientific Advisory Group |
|
SAG |
concePTION, i~HD |
Regulatory |
|
secondary use of data (or data re-use) |
|
|
concePTION, i~HD, AIDAVA |
Information governance |
|
selection bias |
|
|
concePTION, i~HD |
Clinical trials |
|
selective reporting |
|
|
concePTION, i~HD |
Clinical trials |
|
sensitivity |
|
|
concePTION, i~HD |
Clinical trials |
|
sensitivity |
|
|
concePTION, i~HD, AIDAVA |
Information governance |
|
sensitivity |
|
|
concePTION, i~HD |
Pharmacokinetics, Pharmacovigilance |
|
sensitivity analysis |
|
|
concePTION, i~HD |
Statistics |
|
serious adverse event |
|
SAE |
concePTION, i~HD |
Pharmacokinetics, Pharmacovigilance |
|
side effect |
|
|
concePTION, i~HD |
Pharmacokinetics, Pharmacovigilance |
|
sign |
|
|
concePTION, i~HD |
Pharmacokinetics, Pharmacovigilance |
|
signal |
|
|
concePTION, i~HD |
Statistics |
|
signalling pathway |
|
|
concePTION, i~HD |
Biology |
|
significance |
|
|
concePTION, i~HD |
Statistics |
|
significance level |
|
|
concePTION, i~HD |
Statistics |
|
silencing |
|
|
concePTION, i~HD |
Biology |
|
Simcyp® |
|
|
concePTION, i~HD |
Pharmacokinetics, Pharmacovigilance |
|
single ascending dose study |
|
SAD |
concePTION, i~HD |
Clinical trials |
|
social care provider organisation |
|
|
concePTION, i~HD |
Healthcare |
|
soft endpoint |
|
|
concePTION, i~HD |
Clinical trials |
|
somatic |
|
|
concePTION, i~HD |
Biology |
|
specificity |
|
|
concePTION, i~HD |
Statistics |
|
sponsor |
|
|
concePTION, i~HD |
Clinical trials |
|
spontaneous abortion |
|
|
concePTION, i~HD |
Maternity |
|
standard |
|
|
concePTION, i~HD, AIDAVA |
Information and communication technology |
|
standard deviation |
|
|
concePTION, i~HD |
Statistics |
|
statistical analysis plan |
|
SAP |
concePTION, i~HD |
Clinical trials |
|
statistical significance |
|
|
concePTION, i~HD |
Statistics |
|
stem cell therapy |
|
|
concePTION, i~HD |
Biology |
|
stem cells |
|
|
concePTION, i~HD |
Biology |
|
stillbirth |
|
|
concePTION, i~HD |
Maternity |
|
stratification |
|
|
concePTION, i~HD |
Clinical trials |
|
stratified medicine |
|
|
concePTION, i~HD |
Biology |
|
strong authentication |
|
|
concePTION, i~HD, AIDAVA |
Information governance |
|
structure-activity relationships and quantitative structure-activity relationships |
|
SAR/QSAR |
concePTION, i~HD |
Pharmacokinetics, Pharmacovigilance |
|
study participant |
|
|
concePTION, i~HD, AIDAVA |
Information governance |
|
subject of care |
|
|
concePTION, i~HD |
Healthcare |
|
submission |
|
|
concePTION, i~HD |
Regulatory |
|
substances, products, organisations and referentials |
|
SPOR |
concePTION, UNICOM, Gravitate-Health, i~HD |
Medicines |
|
sudden infant death syndrome |
|
SIDS |
concePTION, i~HD |
Maternity |
|
Supervisory Authority |
|
|
concePTION, i~HD, AIDAVA |
Information governance |
|
surrogate endpoint |
|
|
concePTION, i~HD |
Clinical trials |
|
suspected unexpected serious adverse reaction |
|
SUSAR |
concePTION, i~HD |
Pharmacokinetics, Pharmacovigilance |
|
system dependent components |
|
|
concePTION, i~HD |
Biology |
|
t-test |
|
|
concePTION, i~HD |
Statistics |
|
target patient population |
|
|
concePTION, i~HD |
Clinical trials |
|
target product profile |
|
TPP |
concePTION, i~HD |
Clinical trials |
|
targeted medicine |
|
|
concePTION, i~HD |
Medicines |
|
teratogen |
|
|
concePTION, i~HD |
Pharmacokinetics, Pharmacovigilance |
|
teratogenic |
|
|
concePTION, i~HD |
Pharmacokinetics, Pharmacovigilance |
|
teratology |
|
|
concePTION, i~HD |
Pharmacokinetics, Pharmacovigilance |
|
termination of pregnancy |
abortion
|
|
concePTION, i~HD |
Maternity |
|
abortion |
termination of pregnancy
|
|
concePTION, i~HD |
Maternity |
|
testing method |
|
|
concePTION, i~HD |
Pharmacokinetics, Pharmacovigilance |
|
therapeutic alternatives |
|
|
concePTION, i~HD |
Medicines |
|
third sector provider organisation |
|
|
concePTION, i~HD |
Healthcare |
|
time-to-event endpoint |
|
TTE |
concePTION, i~HD |
Clinical trials |
|
tolerability |
|
|
concePTION, i~HD |
Medicines |
|
toxicity |
|
|
concePTION, i~HD |
Pharmacokinetics, Pharmacovigilance |
|
toxicokinetics |
|
|
concePTION, i~HD |
Pharmacokinetics, Pharmacovigilance |
|
TQTc |
|
|
concePTION, i~HD |
Clinical trials |
|
transcriptome |
|
|
concePTION, i~HD |
Biology |
|
transgenic |
|
|
concePTION, i~HD |
Biology |
|
treatment emergent adverse event |
|
TEAE |
concePTION, i~HD |
Pharmacokinetics, Pharmacovigilance |
|
treatment group |
|
|
concePTION, i~HD |
Clinical trials |
|
trial arm |
|
|
concePTION, i~HD |
Clinical trials |
|
trusted third party |
|
TTP |
concePTION, i~HD, AIDAVA |
Information governance |
|
Type I error |
|
|
concePTION, i~HD |
Statistics |
|
Type II error |
|
|
concePTION, i~HD |
Statistics |
|
uncertainty |
|
|
concePTION, i~HD |
Statistics |
|
United States package insert |
|
USPI |
concePTION, i~HD |
Regulatory |
|
validation |
|
|
concePTION, i~HD |
Statistics |
|
variable |
|
|
concePTION, i~HD |
Statistics |
|
variance |
|
|
concePTION, i~HD |
Statistics |
|
vector |
|
|
concePTION, i~HD |
Biology |
|
very low birth weight (baby) |
|
|
concePTION, i~HD |
Maternity |
|
vulnerable participants or populations |
|
|
concePTION, i~HD |
Medicines |
|
wash out period |
|
|
concePTION, i~HD |
Clinical trials |
|
whole genome sequencing |
|
WGS |
concePTION, i~HD |
Biology |
|
workflow |
|
|
concePTION, i~HD |
Healthcare |
|
Z-factor |
|
|
concePTION, i~HD |
Pharmacokinetics, Pharmacovigilance |
|
zygote |
|
|
concePTION, i~HD |
Maternity |
|
active substance |
active ingredient, active pharmaceutical ingredient
|
|
concePTION, OpenMedicine, UNICOM, i~HD |
Medicines |
|
audit trail |
|
|
concePTION, OpenMedicine, i~HD, AIDAVA |
Information governance |
|
authentication |
|
|
concePTION, OpenMedicine, i~HD, AIDAVA |
Information governance |
|
care pathway |
|
|
concePTION, OpenMedicine, i~HD |
Healthcare |
|
data |
|
|
concePTION, OpenMedicine, i~HD, AIDAVA |
Information and communication technology |
|
de-identification |
|
|
concePTION, OpenMedicine, i~HD, AIDAVA |
Information governance |
|
electronic health record |
|
EHR |
concePTION, OpenMedicine, UNICOM, Gravitate-Health, i~HD, AIDAVA, XpanDH, xShare |
Information and communication technology |
|
European Medicines Agency |
|
EMA |
concePTION, OpenMedicine, UNICOM, i~HD, Gravitate-Health |
Medicines |
|
excipient |
|
|
concePTION, OpenMedicine, UNICOM, i~HD |
Medicines |
|
identification of medicinal products |
|
IDMP |
concePTION, OpenMedicine, UNICOM, Gravitate-Health, i~HD, XpanDH |
Medicines |
|
inclusion criteria |
|
|
concePTION, OpenMedicine, i~HD |
Clinical trials |
|
medication |
|
|
concePTION, OpenMedicine, i~HD |
Medicines |
|
medicinal product |
|
MP |
concePTION, OpenMedicine, UNICOM, i~HD |
Healthcare |
|
national competent authority |
national drug authority, national medicines authority
|
NCA |
concePTION, OpenMedicine, UNICOM, i~HD, Gravitate-Health |
Regulatory |
|
national drug authority |
national competent authority, national medicines authority
|
|
concePTION, OpenMedicine, UNICOM, i~HD, Gravitate-Health |
Regulatory |
|
processing |
|
|
concePTION, OpenMedicine, Gravitate-Health, i~HD, AIDAVA |
Information governance |
|
role |
|
|
concePTION, OpenMedicine, i~HD, AIDAVA |
Information governance |
|
serious adverse reaction |
serious ADR
|
SAR |
concePTION, OpenMedicine, UNICOM, i~HD |
Pharmacokinetics, Pharmacovigilance |
|
serious ADR |
serious adverse reaction
|
|
concePTION, OpenMedicine, UNICOM, i~HD |
Pharmacokinetics, Pharmacovigilance |
|
third party |
|
|
concePTION, OpenMedicine, i~HD, AIDAVA |
Information governance |
|
model verification |
|
|
concePTION, i~HD |
Statistics |
|
Spanish Medicine Agency |
|
AEMPS |
UNICOM, i~HD, Gravitate-Health |
|
|
active substance master file |
|
ASMF |
UNICOM, i~HD |
Regulatory |
|
Federal Institute for medicines & medical devices in Germany |
|
BfArM |
UNICOM, i~HD |
|
|
centrally authorised product |
|
CAP |
UNICOM, i~HD |
Regulatory |
|
cross-border eHealth information services |
|
CBeHIS |
UNICOM, i~HD |
|
|
Medicines Evaluation Board of the Netherlands |
|
CBG-MEB |
UNICOM, i~HD |
|
|
combined pharmaceutical dose form |
|
|
UNICOM, i~HD |
|
|
common data model |
|
CDM |
UNICOM, i~HD |
|
|
common European submission portal |
|
CESP |
UNICOM, i~HD |
|
|
Coordination Group for Mutual Recognition and Decentralised Procedures - Human |
|
CMDh |
UNICOM, i~HD |
|
|
Coordination Groups for Mutual Recognition and Decentralised Procedures |
|
CMDs |
UNICOM, i~HD |
|
|
Coordination Group for Mutual Recognition and Decentralised Procedures - Veterinary |
|
CMDv |
UNICOM, i~HD |
|
|
database administrator |
|
DBA |
UNICOM, i~HD |
|
|
decentralised procedure |
|
DCP |
UNICOM, i~HD |
|
|
German substance registration system |
|
DE-SRS |
UNICOM, i~HD |
|
|
Digital Imaging and Communications in Medicine |
|
DICOM |
UNICOM, i~HD |
|
|
electronic application form |
|
eAF |
UNICOM, i~HD |
|
|
European Medicines Regulatory Network |
|
EMRN |
UNICOM, i~HD |
|
|
European risk management strategy |
|
ERMS |
UNICOM, i~HD |
|
|
European Free Trade Association |
|
EFTA |
UNICOM, i~HD |
|
|
European substance registration system |
|
EU-SRS |
UNICOM, i~HD |
|
|
European Union Network Data Board |
|
EUNDB |
UNICOM, i~HD |
|
|
European Union telematics controlled terms |
|
EUTCT |
UNICOM, i~HD |
|
|
global substance registration system |
|
GSRS |
UNICOM, i~HD |
|
|
hyper text transfer protocol |
|
HTTP |
UNICOM, i~HD |
|
|
IRIS Platform |
|
|
UNICOM, i~HD |
|
|
integrated patient management system |
|
IPMS |
UNICOM, i~HD |
|
|
IT Directors Executive Committee |
|
ITDEC |
UNICOM, i~HD |
|
|
Agency for Medicinal Products and Medical Devices of the Republic of Slovenia |
|
JAZMP |
UNICOM, i~HD |
Regulatory |
|
marketing authorisation procedure |
|
MAP |
UNICOM, i~HD |
|
|
market authorisation variation |
|
MAV |
UNICOM, i~HD |
|
|
medical dictionary for regulatory activities |
|
MedDRA |
UNICOM, concePTION, Gravitate-Health, i~HD, xShare |
|
|
Swedish Medical Products Agency |
Medical Products Agency of Sweden
|
SEMPA |
UNICOM, i~HD |
|
|
nationally authorised product |
|
NAP |
UNICOM, i~HD |
|
|
National Centre for Advancing Translational Sciences |
|
NCATS |
UNICOM, i~HD, xShare |
|
|
National Institutes of Health |
|
NIH |
UNICOM, i~HD |
|
|
national medicines authority |
national competent authority, national drug authority
|
NMA |
UNICOM, OpenMedicine, concePTION, i~HD, Gravitate-Health |
|
|
Norwegian Medicines Agency |
|
NoMA |
UNICOM, i~HD |
|
|
national procedure |
|
NP |
UNICOM, i~HD |
|
|
organisation management service |
|
OMS |
UNICOM, i~HD |
|
|
prescribing and dispensing software system |
|
PDSS |
UNICOM, i~HD |
|
|
programme for international drug monitoring |
|
PIDM |
UNICOM, i~HD |
|
|
patient-facing mobile health application |
|
PMHA |
UNICOM, i~HD |
|
|
referential management service |
|
RMS |
UNICOM, i~HD |
|
|
standards knowledge management tool |
|
SKMT |
UNICOM, i~HD |
|
|
substance management service |
|
SMS |
UNICOM, i~HD |
|
|
State Institute for Drug Control of Czech Republic |
|
SUKL |
UNICOM, i~HD |
|
|
Substance Validation Group |
|
SVG |
UNICOM, i~HD |
|
|
Telematics Management Board |
EU Telematics Management Board
|
TMB |
UNICOM, i~HD |
|
|
unit of presentation |
|
UoP |
UNICOM, i~HD |
|
|
eHealth digital service infrastructure |
|
eHDSI |
UNICOM, i~HD, XpanDH, xShare |
|
|
member state of treatment |
country B
|
|
UNICOM, i~HD |
|
|
member state of affiliation |
country A
|
|
UNICOM, i~HD |
|
|
protection of personal data |
|
POPD |
UNICOM, i~HD |
|
|
ethics advisory board |
|
EAB |
UNICOM, i~HD |
|
|
Agency for Healthcare Research and Quality |
|
AHRQ |
UNICOM, i~HD |
Regulatory |
|
primary package |
|
|
UNICOM, i~HD |
|
|
secondary package |
|
|
UNICOM, i~HD |
|
|
GS1 |
|
|
UNICOM, i~HD |
|
|
application programming interface |
|
API |
UNICOM, Gravitate-Health, i~HD, AIDAVA |
Information and communication technology |
|
European Medicines Verification Organisation |
|
EMVO |
UNICOM, i~HD |
|
|
European Union falsified medicines directive |
|
EU-FMD |
UNICOM, i~HD |
|
|
medicinal product dictionary |
medicinal product dictionary system
|
MPD |
UNICOM, OpenMedicine, i~HD |
|
|
Uppsala Monitoring Centre |
|
WHO-UMC |
UNICOM, i~HD |
|
|
country A |
member state of affiliation
|
|
UNICOM, i~HD |
|
|
country B |
member state of treatment
|
|
UNICOM, i~HD |
|
|
national contact point |
|
NCP |
UNICOM, i~HD |
|
|
eHealth |
|
|
UNICOM, i~HD |
|
|
Medicines & Healthcare products Regulatory Agency of the United Kingdom |
|
MHRA |
UNICOM, i~HD |
|
|
Medical Products Agency of Sweden |
Swedish Medical Products Agency
|
MPA |
UNICOM, i~HD |
|
|
fast healthcare interoperability resources |
|
FHIR |
UNICOM, Gravitate-Health, i~HD, AIDAVA, xShare |
Information and communication technology |
|
allergen |
|
|
UNICOM, i~HD |
Healthcare |
|
attribute |
|
|
UNICOM, i~HD, AIDAVA |
Information and communication technology |
|
available prescription |
|
|
UNICOM, i~HD |
eDispensation, ePrescription |
|
clinical information system |
|
|
UNICOM, i~HD |
|
|
coding system |
|
|
UNICOM, i~HD |
|
|
dispensed medicine |
|
|
UNICOM, i~HD |
|
|
dispenser |
|
|
UNICOM, i~HD |
|
|
eDispensation |
eDispensing
|
eD |
UNICOM, i~HD, XpanDH, xShare |
|
|
eHealth Network |
|
eHN |
UNICOM, i~HD, XpanDH, xShare |
|
|
generic medicinal product |
|
|
UNICOM, i~HD |
|
|
guideline |
|
|
UNICOM, i~HD |
|
|
hospital information system |
|
HIS |
UNICOM, i~HD |
|
|
master value sets catalogue |
|
MVC |
UNICOM, i~HD, xShare |
|
|
medical record |
medical health record
|
|
UNICOM, i~HD |
|
|
medication summary |
|
|
UNICOM, i~HD |
|
|
medicinal prescription |
|
|
UNICOM, i~HD |
|
|
posology |
|
|
UNICOM, i~HD |
|
|
prescriber |
|
|
UNICOM, i~HD |
|
|
substance |
|
|
UNICOM, i~HD |
|
|
time valid prescription |
|
|
UNICOM, i~HD |
|
|
valid prescription |
|
|
UNICOM, i~HD |
|
|
Federal Agency for Medicines and Health Products of Belgium |
|
AFMPS |
UNICOM, i~HD |
|
|
Agency for Health and Food Safety in Austria |
|
AGES |
UNICOM, i~HD |
Regulatory |
|
Agency for Food, Environmental and Occupational Health and Safety of France |
|
ANSES |
UNICOM, i~HD |
Regulatory |
|
Clinical Data Interchange Standards Consortium |
|
CDISC |
UNICOM, i~HD, xShare |
|
|
Republic of Estonia Agency of Medicines |
State Agency of Medicines of Estonia
|
EESAM |
UNICOM, i~HD |
|
|
clinical trial information system |
|
CTIS |
UNICOM, i~HD |
|
|
EU Telematics Management Board |
Telematics Management Board
|
EUTMB |
UNICOM, i~HD |
|
|
Finnish Medicines Agency |
|
FIMEA |
UNICOM, i~HD |
|
|
Agency for Medicinal Products and Medicinal Devices of Croatia |
|
HALMED |
UNICOM, i~HD |
Regulatory |
|
Health Level Seven International |
|
HL7 |
UNICOM, i~HD, xShare, Gravitate-Health |
|
|
National Authority of Medicines and Health Products of Portugal |
|
INFARMED |
UNICOM, i~HD |
|
|
product management services |
|
PMS |
UNICOM, i~HD |
|
|
medical health record |
medical record
|
|
UNICOM, i~HD |
|
|
European Federation of Pharmaceutical Industries and Associations |
|
EFPIA |
UNICOM, concePTION, i~HD |
Medicines |
|
Food and Drug Administration of the United States |
|
FDA |
UNICOM, concePTION, i~HD, xShare, Gravitate-Health |
Medicines |
|
standards developing organisation |
|
SDO |
UNICOM, i~HD, XpanDH, xShare |
|
|
lead member state |
|
LMS |
UNICOM, i~HD |
|
|
international nonproprietary names modified |
|
INNM |
UNICOM, i~HD |
|
|
modified substance |
|
|
UNICOM, i~HD |
|
|
virtual medicinal product |
|
VMP |
UNICOM, i~HD |
|
|
virtual medicinal product group |
|
VMP Group |
UNICOM, i~HD |
|
|
actual medicinal product |
|
AMP |
UNICOM, i~HD |
Medicines |
|
actual medicinal product package |
|
AMPP |
UNICOM, i~HD |
Medicines |
|
virtual therapeutic moiety |
|
VTM |
UNICOM, i~HD |
|
|
EU Telematics |
|
|
UNICOM, i~HD |
|
|
State Agency of Medicines of Estonia |
Republic of Estonia Agency of Medicines
|
SAM |
UNICOM, i~HD |
|
|
active ingredient |
active pharmaceutical ingredient, active substance
|
|
concePTION, OpenMedicine, UNICOM, i~HD |
Pharmacokinetics, Pharmacovigilance |
|
clinical decision support |
clinical decision support system
|
CDS |
UNICOM, concePTION, i~HD |
Healthcare |
|
over the counter medicine |
|
OTC |
UNICOM, concePTION, Gravitate-Health, i~HD |
|
|
basis of strength substance |
|
BoSS |
UNICOM, i~HD |
Medicines |
|
precise active ingredient substance |
|
PAI |
UNICOM, i~HD |
|
|
evidence based medicine |
|
EBM |
UNICOM, i~HD |
|
|
electronic medication administration record |
|
eMAR |
UNICOM, i~HD |
|
|
technical specification |
|
TS |
UNICOM, i~HD |
|
|
adverse event following immunisation |
|
AEFI |
UNICOM, i~HD |
Healthcare, Pharmacovigilance |
|
chemical abstracts service |
|
CAS |
UNICOM, i~HD |
Medicines |
|
European Commission |
|
EC |
UNICOM, i~HD, XpanDH, xShare |
|
|
European Union |
|
EU |
UNICOM, i~HD, AIDAVA, XpanDH, xShare, Gravitate-Health |
|
|
National Health Service |
|
NHS |
UNICOM, i~HD, Gravitate-Health |
|
|
standardised drug grouping |
|
SDG |
UNICOM, i~HD |
|
|
substance identifier |
|
SID |
UNICOM, i~HD |
|
|
EudraVigilance |
|
EV |
UNICOM, i~HD |
|
|
VigiBase |
|
|
UNICOM, i~HD |
|
|
defined daily dose |
|
DDD |
UNICOM, i~HD |
Pharmacovigilance |
|
clinical drug |
|
CD Precisely |
UNICOM, i~HD |
Medicines |
|
dictionary of medicines and devices |
|
dm+d |
UNICOM, i~HD |
|
|
international classification of diseases |
international statistical classification of diseases and health related problems
|
ICD |
UNICOM, i~HD, xShare |
|
|
international statistical classification of diseases and health related problems |
international classification of diseases
|
ICD |
UNICOM, i~HD, xShare |
|
|
linked open data |
|
LOD |
UNICOM, i~HD |
|
|
medical subject headings |
|
MeSH |
UNICOM, i~HD |
|
|
National Library of Medicine of the United States |
|
NLM |
UNICOM, i~HD |
|
|
ministry of health |
|
MoH |
UNICOM, i~HD, xShare |
|
|
medicinal product containing only |
|
MP-only |
UNICOM, i~HD |
|
|
potentially inappropriate medication list |
|
PIM list |
UNICOM, i~HD |
|
|
patient reported experience measures |
|
PREMs |
UNICOM, i~HD |
|
|
Source Authentique des Médicaments |
|
SAM |
UNICOM, i~HD |
|
|
unified medical language system |
|
UMLS |
UNICOM, i~HD |
|
|
unique ingredient identifier |
|
UNII |
UNICOM, i~HD |
|
|
communication and tracking system |
|
CTS |
UNICOM, i~HD |
|
|
user acceptance testing |
|
UAT |
UNICOM, i~HD |
|
|
work package |
|
WP |
UNICOM, i~HD, XpanDH, xShare |
Contractual and project management |
|
IT system/database for drug data at EESAM |
|
SamTrack |
UNICOM, i~HD |
|
|
pilot product list |
|
PPL |
UNICOM, i~HD |
|
|
Federal Office for Safety in Health Care in Austria |
|
BASG |
UNICOM, i~HD |
|
|
description of action |
|
DoA |
UNICOM, i~HD, XpanDH, Gravitate-Health |
Contractual and project management |
|
implementation guide |
|
IG |
UNICOM, i~HD, XpanDH |
|
|
business segment of AGES medicines & medical devices agency (AGES) in Austria |
|
MEA |
UNICOM, i~HD |
|
|
project manager |
|
PM |
UNICOM, i~HD |
|
|
Digital Application Dataset Integration Project |
|
DADI |
UNICOM, i~HD |
|
|
relational data model |
|
RDM |
UNICOM, i~HD |
|
|
integrated regulatory information system |
|
iRis |
UNICOM, i~HD |
|
|
user interface |
|
UI |
UNICOM, Gravitate-Health, i~HD |
|
|
user experience |
|
UX |
UNICOM, Gravitate-Health, i~HD |
|
|
WinPure |
|
|
UNICOM, i~HD |
|
|
Health Products Regulatory Authority in Ireland |
|
HPRA |
UNICOM, i~HD |
|
|
HPRA case management system |
|
EOLAS |
UNICOM, i~HD |
|
|
union product database |
|
UPD |
UNICOM, i~HD |
|
|
FIMEA's new medicines registry |
|
Saga |
UNICOM, i~HD |
|
|
secure shell file transfer protocol |
|
SFTP |
UNICOM, i~HD |
Information and communication technology |
|
Institute for Health and Welfare of Finland |
|
THL |
UNICOM, i~HD |
|
|
national organisations repository of National Authority of Medicines and Health Products of Portugal |
|
GENT |
UNICOM, i~HD |
|
|
INFARMED national repository of medicinal products |
|
GiMED |
UNICOM, i~HD |
|
|
INFARMED national substances repository |
|
GSUB |
UNICOM, i~HD |
|
|
International Organization for Standardization for the identification of medicinal products |
|
ISO IDMP |
UNICOM, i~HD, Gravitate-Health |
|
|
standard operating procedure |
|
SOP |
UNICOM, i~HD |
|
|
Centre for Pharmacological Information in Belgium |
|
BCFI |
UNICOM, i~HD |
|
|
dossiers tracking system |
|
DTS |
UNICOM, i~HD |
|
|
INFARMED national reference data management system |
|
GDR |
UNICOM, i~HD |
|
|
extra plus revised |
|
E + R |
UNICOM, i~HD |
|
|
health intelligence reporting system |
|
HIRS |
UNICOM, i~HD |
|
|
national institute for health and disability insurance in Belgium |
|
RIZIV/INAMI |
UNICOM, i~HD |
|
|
workflow system used by the Federal Agency of Medecines and Health Products of Belgium |
|
MeSeA |
UNICOM, i~HD |
|
|
medicinal product management |
|
MPM |
UNICOM, i~HD |
|
|
OMS organisation identifier |
|
org-id |
UNICOM, i~HD |
|
|
marketing authorisation holders for veterinary products |
|
VET-MAH's |
UNICOM, i~HD |
|
|
infrastructure as a service |
|
IaaS |
UNICOM, i~HD |
|
|
platform as a service |
|
PaaS |
UNICOM, i~HD, AIDAVA |
Information and communication technology |
|
assessment and evaluation tools for e-service deployment in health, care and ageing |
|
ASSIST |
Gravitate-Health, i~HD, UNICOM |
Information and communication technology |
|
semantic clinical drug |
|
SCD |
UNICOM, i~HD |
|
|
defined daily doses per 1000 inhabitants per day |
|
DID |
UNICOM, i~HD |
|
|
single-dose container |
|
|
UNICOM, i~HD |
Medicines |
|
unit-dose blister |
|
|
UNICOM, i~HD |
eDispensation, ePrescription |
|
FAIR principles |
|
|
Gravitate-Health, i~HD, AIDAVA, UNICOM |
Information governance |
|
Connecting Europe Facility |
|
CEF |
UNICOM, i~HD |
|
|
European Commission |
|
EC |
UNICOM, i~HD, AIDAVA, xShare, Gravitate-Health |
|
|
eHealth Member States Experts Group |
|
eHMSEG |
UNICOM, i~HD |
|
|
EMA IDMP implementation guide V2 |
|
EMA IG V2 |
UNICOM, i~HD |
|
|
electronic product information |
|
ePI |
UNICOM, i~HD, Gravitate-Health |
Regulatory |
|
EU IDMP Implementation Guide |
|
EU IG |
UNICOM, i~HD |
|
|
medicinal product dictionary |
|
MPD |
UNICOM, i~HD |
|
|
pharmaceutical product |
|
PhP |
UNICOM, i~HD |
Medicines |
|
UNICOM FHIR IDMP server |
|
UFIS |
UNICOM |
Information and communication technology |
|
product lifecycle management portal |
|
PLM |
UNICOM |
|
|
European Association of Hospital Pharmacists |
|
EAHP |
UNICOM |
|
|
European Association of E-Pharmacies |
|
EAEP |
UNICOM |
|
|
Pharmaceutical Group of the European Union |
|
PGEU |
UNICOM |
|
|
Global IDMP Working Group |
|
GIDWG |
UNICOM |
|
|
project coordinator |
|
PC |
UNICOM |
|
|
project coordination committee |
|
PCC |
UNICOM |
|
|
project coordination team |
|
PCT |
UNICOM |
|
|
project executive committee |
|
PEC |
UNICOM |
|
|
project management team |
|
PMT |
UNICOM |
|
|
project officer |
|
PO |
UNICOM |
|
|
strategy board |
|
SB |
UNICOM |
|
|
small and medium-sized enterprises |
|
SMEs |
UNICOM |
|
|
scientific and technical coordination office |
|
STCO |
UNICOM |
|
|
work package leader |
|
WPL |
UNICOM |
|
|
cost-benefit analysis |
|
CBA |
UNICOM |
|
|
EMA common repository |
|
EMA CR |
UNICOM |
|
|
drug information centre |
|
DIC |
UNICOM |
|
|
European Interoperability Framework |
|
EIF |
UNICOM |
|
|
Joint Research Centre |
|
JRC |
UNICOM |
|
|
key performance indicator |
|
KPI |
UNICOM |
|
|
maple language file |
|
MPL |
UNICOM |
|
|
national repository for medicinal products in Sweden |
|
NPL |
UNICOM |
|
|
national medicinal products registry of Croatia |
|
NRL |
UNICOM |
|
|
portable document format |
|
PDF |
UNICOM |
|
|
quality assurance |
|
QA |
UNICOM |
|
|
reference data model |
|
RDM |
UNICOM |
|
|
Swedish krona |
|
SEK |
UNICOM |
|
|
INFARMED platform for submission of variation applications |
|
SMUH‐ALTER |
UNICOM |
|
|
substances, products, intressent (organisation), referentials, automation |
|
SPIRA |
UNICOM |
|
|
Shared Services of the Ministry of Health in Portugal |
|
SPMS |
UNICOM |
|
|
Extensible Markup Language |
|
XML |
UNICOM |
|
|
comma-separated values |
|
CSV |
UNICOM |
|
|
electronic common technical document |
|
eCTD |
UNICOM |
|
|
global substance identifier |
|
GSID |
UNICOM |
|
|
integrated taxonomic information system |
|
ITIS |
UNICOM |
|
|
kyoto encyclopedia of genes and genomes |
|
KEGG |
UNICOM |
|
|
medicinal plant names services |
|
MPNS |
UNICOM |
|
|
National Center for Biotechnology Information |
|
NCBI |
UNICOM |
|
|
National Cancer Institute |
|
NCI |
UNICOM |
|
|
substance management services identifier |
|
SMSID |
UNICOM |
|
|
specified substance group 1 |
|
SSG1 |
UNICOM |
|
|
substance validation group identifier |
|
SVGID, SVGID |
UNICOM |
|
|
Uppsala Monitoring Centre substance registration system |
|
UMC-SRS |
UNICOM |
|
|
veterinary ATC |
|
VATC |
UNICOM |
|
|
Systematic Nomenclature of Medicine International |
|
SNOMED International |
UNICOM |
|
|
additional listing name |
|
AL |
UNICOM |
|
|
british pharmacopoeia |
|
BP |
UNICOM |
|
|
dalton |
|
Da |
UNICOM |
|
|
display name |
|
DN |
UNICOM |
|
|
deoxyribonucleic acid |
|
DNA |
UNICOM |
|
|
ethylenediaminetetraacetic acid |
|
EDTA |
UNICOM |
|
|
eudravigilance medicinal product dictionary |
|
EVMPD |
UNICOM |
|
|
Homöopathisches Arzneibuch/German Homoeopathic Pharmacopoeia |
|
HAB/GHP |
UNICOM |
|
|
International Committee on Taxonomy of Viruses |
|
ICTV |
UNICOM |
|
|
immunoglobulin g |
|
IGG |
UNICOM |
|
|
inn proposed list |
|
INN PL |
UNICOM |
|
|
inn recommended list |
|
INN RL |
UNICOM |
|
|
International Organisation for Standardization technical specifications |
|
ISO/TS |
UNICOM |
|
|
International Union of Pure and Applied Chemistry |
|
IUPAC |
UNICOM |
|
|
list of prokaryotic names with standing in nomenclature |
|
LSPN |
UNICOM |
|
|
monoclonal antibody |
|
MAB |
UNICOM |
|
|
messenger ribonucleic acid |
|
mRNA |
UNICOM |
|
|
european pharmacopoeia |
|
Ph. Eur. |
UNICOM |
|
|
french pharmacopoeia |
|
Ph. Fr. |
UNICOM |
|
|
proposed INN |
|
pINN |
UNICOM |
|
|
recommended INN |
|
rINN |
UNICOM |
|
|
preferred term |
|
PT |
UNICOM |
|
|
ribonucleic acid |
|
RNA |
UNICOM |
|
|
simplified molecular-input line-entry system |
|
SMILES |
UNICOM |
|
|
specified substance group |
|
SSG |
UNICOM |
|
|
scientific and technical information network |
|
STN |
UNICOM |
|
|
tumor necrosis factor |
|
TNF |
UNICOM |
|
|
United States |
|
US |
UNICOM |
|
|
United States adopted name |
|
USAN |
UNICOM |
|
|
consortium agreement |
|
CA |
i~HD, AIDAVA, XpanDH, Gravitate-Health |
Contractual and project management |
|
European health data space |
|
EHDS |
i~HD, AIDAVA, XpanDH, xShare, Gravitate-Health |
Digital Service Infrastructure |
|
Health Data Intermediary |
|
HDI |
i~HD, AIDAVA |
Healthcare |
|
basic local alignment search tool |
|
BLAST |
UNICOM |
|
|
javascript object notation |
|
JSON |
UNICOM |
|
|
common specifications |
European EHRxF specifications
|
|
i~HD, XpanDH, xShare |
Digital Service Infrastructure |
|
common content specifications |
|
|
i~HD, XpanDH, xShare |
Digital Service Infrastructure |
|
electronic health data |
|
|
i~HD, XpanDH, xShare |
Digital Service Infrastructure |
|
priority categories of electronic health data |
|
|
i~HD, XpanDH, xShare |
|
|
European electronic health record exchange format |
|
EEHRxF |
i~HD, XpanDH, xShare |
|
|
electronic health record exchange format |
|
EHRxF |
i~HD, XpanDH, xShare |
|
|
patient generated health data |
|
PGHD |
i~HD, XpanDH, xShare |
Information governance |
|
regulator |
|
|
i~HD, XpanDH, xShare |
Regulatory |
|
exchanging electronic health records in a common framework |
|
X-eHealth |
i~HD, XpanDH, xShare |
Digital Service Infrastructure |
|
European EHRxF specifications |
common specifications
|
|
i~HD, XpanDH, xShare |
|
|
expanding digital health through a pan-European EHRxF-based ecosystem |
|
XpanDH |
i~HD, XpanDH, xShare |
|
|
experimentation bubble |
|
X-Bubble |
i~HD, XpanDH, xShare |
|
|
X-Bundle |
|
|
i~HD, XpanDH, xShare |
Digital Service Infrastructure |
|
X-Net |
|
|
i~HD, XpanDH, xShare |
|
|
common data element |
|
|
i~HD, XpanDH, xShare |
Digital Service Infrastructure |
|
sandbox |
|
|
i~HD, xShare |
Digital Service Infrastructure |
|
industry trade association |
national trade association
|
|
i~HD, xShare |
Generic |
|
industry forum |
|
|
i~HD, xShare |
|
|
regulators forum |
|
|
i~HD, xShare |
|
|
sustainable by design |
|
|
i~HD, XpanDH, xShare |
|
|
health information domain |
|
HID |
i~HD, XpanDH, xShare |
|
|
prioritised health information domain |
|
|
i~HD, XpanDH, xShare |
Digital Service Infrastructure |
|
refined eHealth European interoperability framework |
|
ReEIF |
i~HD, XpanDH, xShare |
|
|
extended EHR@EU data space for primary use |
|
Xt-EHR |
i~HD, XpanDH, xShare |
|
|
MyHealth@EU |
|
|
i~HD, XpanDH, xShare |
Digital Service Infrastructure |
|
my health space |
|
|
i~HD, xShare |
Digital Service Infrastructure |
|
health priority focus area |
|
|
i~HD, XpanDH, xShare |
|
|
adoption domain |
|
|
i~HD, XpanDH, xShare |
|
|
xShare button |
xShare yellow button
|
|
i~HD, xShare |
|
|
expanding the European EHRxF to share and effectively use health data within the EHDS |
|
xShare |
i~HD, UNICOM |
|
|
EU xShare label |
|
|
i~HD, xShare |
|
|
European Union digital identity |
|
EUDI |
i~HD, xShare |
Digital Service Infrastructure |
|
EUDI wallet |
|
|
i~HD, xShare |
Digital Service Infrastructure |
|
HealthData@EU |
|
|
i~HD, XpanDH, xShare |
|
|
Health Level Seven |
|
HL7 |
UNICOM |
|
|
HL7 Europe Foundation |
|
HL7 Europe |
i~HD, XpanDH, xShare |
|
|
Integrating the Healthcare Enterprise Europe |
|
IHE Europe |
i~HD, XpanDH, xShare |
|
|
European Committee for Standardization |
|
CEN |
i~HD, XpanDH, xShare |
|
|
Institute of Electrical and Electronics Engineers |
|
IEEE |
i~HD, xShare |
|
|
Integrating the Healthcare Enterprise |
|
IHE |
i~HD, XpanDH, xShare |
|
|
European health data space for primary use of electronic health data |
|
EHDS-1 |
i~HD, XpanDH, xShare |
|
|
European health data space for secondary use of electronic health data |
|
EHDS-2 |
i~HD, XpanDH, xShare |
|
|
FHIR Implementation Guide |
|
FHIR IG |
i~HD, XpanDH, xShare |
|
|
coronavirus disease 2019 |
|
COVID-19 |
i~HD, xShare |
|
|
massive open on-line course |
|
MOOC |
i~HD, xShare |
|
|
electronic identification and trust services |
|
eIDAS |
i~HD, XpanDH, xShare |
|
|
European CRO Federation |
|
EUCROF |
i~HD, xShare |
|
|
clinical data acquisition standards harmonization |
|
CDASH |
i~HD, xShare |
|
|
electronic health record systems for clinical research |
|
EHR4CR |
i~HD, xShare |
|
|
electronic health record systems to electronic data capture |
|
EHR2EDC |
i~HD, xShare |
|
|
population health information research infrastructure |
|
PHIRI |
i~HD, xShare |
|
|
code supervisory body |
|
COSUP |
i~HD, xShare |
|
|
Pharmaceuticals and Medical Devices Agency of Japan |
|
PMDA |
i~HD, xShare |
|
|
human computer interaction |
|
HCI |
AIDAVA |
Information and communication technology |
|
SVG substance registration system |
|
SVG-SRS |
UNICOM |
|
|
Italian Medicines Agency |
|
AIFA |
UNICOM |
|
|
French Agency for Safety of Medicines and Health Products |
|
ANSM |
UNICOM |
|
|
Paul Ehrlich Institute |
|
PEI |
UNICOM |
|
|
clinical trial information system - business intelligence system |
|
CTIS BI |
UNICOM |
|
|
international coalition of medicines regulatory authorities |
|
ICMRA |
UNICOM |
|
|
national trade association |
industry trade association
|
NTA |
xShare, i~HD |
|
|
Digital Single Market |
|
DSM |
XpanDH |
|
|
Centre for Documentation and Costing of Hospital Services in Greece |
|
DRG Institute |
XpanDH |
|
|
DRG coding guidelines in Greece |
|
EKOK |
XpanDH |
|
|
medical procedure classification in Greece |
|
ETIP |
XpanDH |
|
|
National Organization for Provision of Health Services in Greece |
|
EOPYY |
XpanDH |
|
|
digital consumer health product |
|
DCHP |
XpanDH |
|
|
research ethics committee |
|
REC |
XpanDH |
Contractual and project management |
|
European reference network |
|
ERN |
XpanDH |
|
|
international classification of diseases - 10th revision |
|
ICD-10 |
XpanDH |
|
|
information and communications technology |
|
ICT |
XpanDH |
|
|
organisation for quality assurance in health in Greece |
|
ODIPY |
XpanDH |
|
|
Digital Health Europe round tables |
|
RT |
XpanDH |
|
|
surgical site infection |
|
SSI |
XpanDH |
|
|
task |
|
T |
UNICOM, XpanDH |
Contractual and project management |
|
reporting period |
|
RP |
XpanDH |
Contractual and project management |
|
mutual insurance mechanism |
|
MIM |
XpanDH |
Contractual and project management |
|
grant agreement |
|
GA |
XpanDH |
Contractual and project management |
|
artificial intelligence act |
|
AI Act |
XpanDH |
|
|
business to business |
|
B2B |
XpanDH |
|
|
business to consumer |
|
B2C |
XpanDH |
|
|
business to government |
|
B2G |
XpanDH |
|
|
cyber resilience act |
|
CRA |
XpanDH |
|
|
cybersecurity act |
|
CSA |
XpanDH |
|
|
data protection impact assessment |
|
DPIA |
XpanDH |
|
|
electronic identification |
|
eID |
XpanDH |
|
|
findable, accessible, interoperable, reusable |
|
FAIR |
XpanDH |
Information governance |
|
EU recovery and resilience facility |
|
RRF |
XpanDH |
|
|
Agency for Integration, Diffusion and Archive of Medical Information |
|
AIDA |
XpanDH |
|
|
diagnosis related group |
|
DRG |
XpanDH |
|
|
Greek medical procedure classification |
|
GMPC |
XpanDH |
|
|
DRG system in Greece |
|
GrDRG |
XpanDH |
|
|
cross-enterprise document sharing |
|
XDS |
XpanDH |
|
|
dissemination, communication, outreach and exploitation plan |
|
DCOEP |
XpanDH |
Contractual and project management |
|
dissemination, communication, outreach, and exploitation |
|
DCOE |
XpanDH |
Contractual and project management |
|
European Health and Digital Executive Agency |
|
HaDEA |
XpanDH |
Contractual and project management |
|
co-creation community of patients, professionals and programmers |
|
3Cs-3Ps |
XpanDH |
|
|
electronic health record system |
|
EHR-S |
XpanDH, xShare |
|
|
eHDSI Operational Management Board |
|
eHOMB |
xShare |
|
|
Joint Action Towards the European Health Data Space |
|
TEHDAS |
xShare |
|
|
Joint Action Towards the European Health Data Space 2 |
|
TEHDAS2 |
xShare |
|
|
xShare yellow button |
xShare button
|
|
xShare, i~HD |
|